Artivion Inc (AORT) Income Statement

An income statement shows a company's revenue, expenses, and profit over a reporting period.

Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide.

Total Revenue Chart for Artivion Inc

Artivion Inc (AORT) revenue for FY2025 was USD 441.3M, a 13.6% change from FY2024. Artivion Inc's revenue grew from USD 15.3M in 1991 to USD 441.3M in 2025 (2784.5% over 34 years). Earnings per share grew from USD 0.11 in 2017 to USD -0.48 in 2022 (-549.8%). Revenue compound annual growth rate: 5-year CAGR of 11.8%, 10-year CAGR of 11.7%, 20-year CAGR of 9.7%.

The most recent 8 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Revenue (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$1.14B
Implied Share Price
$23.30
Enterprise Value
$1.49B
Revenue (TTM)
$471.47M
EBITDA
$63.72M
Profit Margin
-0.67%
Trailing P/E
—
Forward P/E
35.97
Price/Book (MRQ)
2.61
Price/Sales (TTM)
2.41
EV/EBITDA
29.28
EV/Revenue
3.17
Dividend Yield
—
Book Value
$9.15
Free Cash Flow (FY2025)
-$911,000.00
Free Cash Flow Yield
-0.08%

Snapshot as of 24th October 2026 — not point-in-time controlled, may lag the live market by a few days.